Skip to content

Author

M. Rinella

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Review Article: Fibrosis Reversal in Metabolic Dysfunction-Associated Steatohepatitis-The Promise of Emerging Therapeutics.

BACKGROUND Metabolic dysfunction-associated steatohepatitis (MASH) is a leading indication for liver transplantation, and fibrosis stage most strongly predicts clinical outcomes. Pharmacologic treatment is now available with resmetirom and semaglutide holding conditional approval. AIMS To describe the therapeutic lan...

Malek Ayoub, Tsubasa Tsutsumi, M. Rinella · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.